ICUI
Price
$130.21
Change
+$3.32 (+2.62%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
2.55B
Earnings call today
STXS
Price
$2.20
Change
-$0.05 (-2.22%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
214.36M
Earnings call today
Interact to see
Advertisement

ICUI vs STXS

Header iconICUI vs STXS Comparison
Open Charts ICUI vs STXSBanner chart's image
ICU Medical
Price$130.21
Change+$3.32 (+2.62%)
Volume$9.72K
Capitalization2.55B
Stereotaxis
Price$2.20
Change-$0.05 (-2.22%)
Volume$585
Capitalization214.36M
ICUI vs STXS Comparison Chart in %
Loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICUI vs. STXS commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Hold and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ICUI: $126.89 vs. STXS: $2.25)
Brand notoriety: ICUI and STXS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICUI: 114% vs. STXS: 52%
Market capitalization -- ICUI: $2.55B vs. STXS: $214.36M
ICUI [@Medical Specialties] is valued at $2.55B. STXS’s [@Medical Specialties] market capitalization is $214.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • ICUI’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ICUI is a better buy in the long-term than STXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 4 bullish TA indicator(s).

  • ICUI’s TA Score: 5 bullish, 3 bearish.
  • STXS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than STXS.

Price Growth

ICUI (@Medical Specialties) experienced а +1.13% price change this week, while STXS (@Medical Specialties) price change was -6.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.65%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -3.32%.

Reported Earning Dates

ICUI is expected to report earnings on Aug 07, 2025.

STXS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than STXS($214M). STXS YTD gains are higher at: -1.316 vs. ICUI (-18.225). ICUI has higher annual earnings (EBITDA): 253M vs. STXS (-21.24M). ICUI has more cash in the bank: 255M vs. STXS (19.8M). STXS has less debt than ICUI: STXS (5.49M) vs ICUI (1.7B). ICUI has higher revenues than STXS: ICUI (2.26B) vs STXS (26.8M).
ICUISTXSICUI / STXS
Capitalization2.55B214M1,190%
EBITDA253M-21.24M-1,191%
Gain YTD-18.225-1.3161,385%
P/E Ratio333.33N/A-
Revenue2.26B26.8M8,429%
Total Cash255M19.8M1,288%
Total Debt1.7B5.49M31,038%
FUNDAMENTALS RATINGS
ICUI vs STXS: Fundamental Ratings
ICUI
STXS
OUTLOOK RATING
1..100
6583
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
6151
P/E GROWTH RATING
1..100
261
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (92) in the Medical Specialties industry is in the same range as STXS (92). This means that ICUI’s stock grew similarly to STXS’s over the last 12 months.

ICUI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STXS (100). This means that ICUI’s stock grew similarly to STXS’s over the last 12 months.

ICUI's SMR Rating (92) in the Medical Specialties industry is in the same range as STXS (100). This means that ICUI’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (51) in the Medical Specialties industry is in the same range as ICUI (61). This means that STXS’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is somewhat better than the same rating for STXS (61). This means that ICUI’s stock grew somewhat faster than STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUISTXS
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
66%
Bullish Trend 25 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAJFF28.32N/A
N/A
Canon, Inc.
CMOPF75.00N/A
N/A
Cosmo Pharmaceuticals NV
UVRBF1.50N/A
N/A
Universal Robina
DIGTF0.02N/A
N/A
Thruvision Group PLC
PRTT0.65N/A
N/A
Protect Pharmaceutical Corp

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-1.65%
CLPT - ICUI
57%
Loosely correlated
+2.47%
NVST - ICUI
50%
Loosely correlated
-1.79%
A - ICUI
49%
Loosely correlated
-1.44%
CERS - ICUI
46%
Loosely correlated
+0.78%
RVTY - ICUI
46%
Loosely correlated
-3.13%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+0.45%
SMTI - STXS
40%
Loosely correlated
+0.12%
TWST - STXS
36%
Loosely correlated
-5.89%
CERS - STXS
35%
Loosely correlated
+0.78%
ICUI - STXS
35%
Loosely correlated
-1.65%
RGEN - STXS
33%
Poorly correlated
-3.26%
More